These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 36232909)

  • 41. mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies.
    Caccamo A; Magrì A; Medina DX; Wisely EV; López-Aranda MF; Silva AJ; Oddo S
    Aging Cell; 2013 Jun; 12(3):370-80. PubMed ID: 23425014
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The protective underlying mechanisms of Schisandrin on SH-SY5Y cell model of Alzheimer's disease.
    Zhao ZY; Zhang YQ; Zhang YH; Wei XZ; Wang H; Zhang M; Yang ZJ; Zhang CH
    J Toxicol Environ Health A; 2019; 82(19):1019-1026. PubMed ID: 31739764
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genistein protects against amyloid-beta-induced toxicity in SH-SY5Y cells by regulation of Akt and Tau phosphorylation.
    Petry FDS; Coelho BP; Gaelzer MM; Kreutz F; Guma FTCR; Salbego CG; Trindade VMT
    Phytother Res; 2020 Apr; 34(4):796-807. PubMed ID: 31795012
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Complement C3a receptor antagonist attenuates tau hyperphosphorylation via glycogen synthase kinase 3β signaling pathways.
    Hu J; Yang Y; Wang M; Yao Y; Chang Y; He Q; Ma R; Li G
    Eur J Pharmacol; 2019 May; 850():135-140. PubMed ID: 30771350
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice.
    Umeda T; Maekawa S; Kimura T; Takashima A; Tomiyama T; Mori H
    Acta Neuropathol; 2014 May; 127(5):685-98. PubMed ID: 24531886
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The binding and phosphorylation of Thr231 is critical for Tau's hyperphosphorylation and functional regulation by glycogen synthase kinase 3beta.
    Lin YT; Cheng JT; Liang LC; Ko CY; Lo YK; Lu PJ
    J Neurochem; 2007 Oct; 103(2):802-13. PubMed ID: 17680984
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A new non-aggregative splicing isoform of human Tau is decreased in Alzheimer's disease.
    García-Escudero V; Ruiz-Gabarre D; Gargini R; Pérez M; García E; Cuadros R; Hernández IH; Cabrera JR; García-Escudero R; Lucas JJ; Hernández F; Ávila J
    Acta Neuropathol; 2021 Jul; 142(1):159-177. PubMed ID: 33934221
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microtubule-affinity regulating kinase family members distinctively affect tau phosphorylation and promote its toxicity in a Drosophila model.
    Sultanakhmetov G; Kato I; Asada A; Saito T; Ando K
    Genes Cells; 2024 Apr; 29(4):337-346. PubMed ID: 38329182
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Caspase-3-dependent cleavage of Akt modulates tau phosphorylation via GSK3β kinase: implications for Alzheimer's disease.
    Chu J; Lauretti E; Praticò D
    Mol Psychiatry; 2017 Jul; 22(7):1002-1008. PubMed ID: 28138159
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer's disease and PART.
    Kaufman SK; Del Tredici K; Thomas TL; Braak H; Diamond MI
    Acta Neuropathol; 2018 Jul; 136(1):57-67. PubMed ID: 29752551
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons.
    Takashima A; Honda T; Yasutake K; Michel G; Murayama O; Murayama M; Ishiguro K; Yamaguchi H
    Neurosci Res; 1998 Aug; 31(4):317-23. PubMed ID: 9809590
    [TBL] [Abstract][Full Text] [Related]  

  • 52. NUB1 modulation of GSK3β reduces tau aggregation.
    Richet E; Pooler AM; Rodriguez T; Novoselov SS; Schmidtke G; Groettrup M; Hanger DP; Cheetham ME; van der Spuy J
    Hum Mol Genet; 2012 Dec; 21(24):5254-67. PubMed ID: 22965877
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Melatonin ameliorates amyloid beta-induced memory deficits, tau hyperphosphorylation and neurodegeneration via PI3/Akt/GSk3β pathway in the mouse hippocampus.
    Ali T; Kim MO
    J Pineal Res; 2015 Aug; 59(1):47-59. PubMed ID: 25858697
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Selenium treatment significantly inhibits tumor necrosis factor-α-induced cell death and tau hyperphosphorylation in neuroblastoma cells.
    Lee YJ; Kim JE; Kwak MH; Go J; Yang SY; Kwon HS; Kim BC; Kim JM; Hwang DY
    Mol Med Rep; 2014 Oct; 10(4):1869-74. PubMed ID: 25109896
    [TBL] [Abstract][Full Text] [Related]  

  • 55. NAP Protects against Tau Hyperphosphorylation Through GSK3.
    Ivashko-Pachima Y; Gozes I
    Curr Pharm Des; 2018; 24(33):3868-3877. PubMed ID: 30417779
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oral (-)-Epicatechin Inhibits Progressive Tau Pathology in rTg4510 Mice Independent of Direct Actions at GSK3β.
    Hole KL; Staniaszek LE; Menon Balan G; Mason JM; Brown JT; Williams RJ
    Front Neurosci; 2021; 15():697319. PubMed ID: 34220446
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Beta-amyloid1-42 gene transfer model exhibits intraneuronal amyloid, gliosis, tau phosphorylation, and neuronal loss.
    Rebeck GW; Hoe HS; Moussa CE
    J Biol Chem; 2010 Mar; 285(10):7440-6. PubMed ID: 20071340
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glycogen synthase kinase 3beta phosphorylates Alzheimer's disease-specific Ser396 of microtubule-associated protein tau by a sequential mechanism.
    Li T; Paudel HK
    Biochemistry; 2006 Mar; 45(10):3125-33. PubMed ID: 16519507
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Active c-jun N-terminal kinase induces caspase cleavage of tau and additional phosphorylation by GSK-3beta is required for tau aggregation.
    Sahara N; Murayama M; Lee B; Park JM; Lagalwar S; Binder LI; Takashima A
    Eur J Neurosci; 2008 Jun; 27(11):2897-906. PubMed ID: 18540881
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Puerarin inhibits β‑amyloid peptide 1‑42‑induced tau hyperphosphorylation via the Wnt/β‑catenin signaling pathway.
    Yao Y; Chen X; Bao Y; Wu Y
    Mol Med Rep; 2017 Dec; 16(6):9081-9085. PubMed ID: 28990074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.